Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited Standalone Financial Results of the Company for the Quarter and Year ended March 31, 2026.
Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026
Filed with BSE · · 1 page · English
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Apr 06 2026
- Regulation 31(4) - SAST Disclosure
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 30 2026
- Announcement under Regulation 30 (LODR)-Change in Management
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Mar 27 2026
Later from Venmax Drugs & Pharmaceuticals
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2026
- Announcement under Regulation 30 (LODR)-Allotment
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals